Welcome to the Premium edition of How They Make Money. Over 200,000 subscribers turn to us for business and investment insights.
In case you missed it: Intel just got a much-needed $5 billion boostYears of missed timelines and swelling capex turned Intel’s foundry ambitions into a cash drain, and confidence in a quick catch-up faded. On the latest earnings call, CEO Lip-Bu Tan said the next-generation chip node (14A) would only work with a “meaningful external customer” to share the spend. That warning served as leverage. Either put real capital behind Intel’s foundry, or accept a future where Intel designs chips but gets them built at TSMC.
That one-two punch (policy support and a new marquee partner) doesn’t fix execution overnight, but it resets the board for America's AI ambitions. Meanwhile, in a move to secure its own ecosystem, Europe saw lithography leader ASML take a strategic 11% stake in Mistral AI to integrate AI across its product portfolio and accelerate the chip design process. Let’s break it down. Today at a glance:
FROM OUR PARTNERS An AI ‘Breakthrough’ with FDA Submission on the Horizon
FDA clearance is a major milestone for any medical innovation. Investors watch for this, because passing FDA trials can be a potential major milestone opening greater opportunities for growth and even acquisition. For HeartSciences (Nasdaq: HSCS), they’ve already received an FDA Breakthrough Device Designation, and their FDA submission is next. The company has also created a software platform which is expected to offer an AI algorithm “app store” to help radically upgrade the ECG, a common heart test used by frontline healthcare workers, to detect a broader range of heart disease, earlier. The ECG is performed up to 1 billion times on patients annually, and the ECG market is projected to reach $30B by 2034. That’s why one Wall Street analyst has a price target of $15 for HeartSciences’ stock. But today, you can invest at just $3.50 per unit (convertible preferred stock + warrant). With the analyst target, this represents more than 500% potential upside. Learn more and invest in HeartSciences. This is a paid advertisement for HeartSciences Regulation A+ offering. Please read the offering circular at https://invest.heartsciences.com/
1. The Race for AI's FoundationBefore we break down the Intel-NVIDIA deal, we need to map the handful of companies that control the world's supply of AI chips. The AI tech stack has 3 layers:
Let’s focus on the foundational bottom layer: the world of compute.
Why it mattersMost leading-edge logic for AI training/inference is built at Taiwan Semiconductor Manufacturing Company, or TSMC for short (with Samsung a distant second). Concentrating that capability in one company on one island creates national security and supply chain risk for the US. Intel is the only domestic path to on-shore leading-edge logic and advanced packaging at meaningful scale, which is why policymakers treat it as strategic infrastructure. Intel vs. TSMC
How we got here
The AI sovereignty crisisThe reason for the urgency is simple: the entire AI revolution, from training efficiency to memory bandwidth, is built on the most advanced chips available. As this technology becomes critical infrastructure for both the US industry and its national defense, relying on a single, overseas point of failure becomes an existential threat. Now, let’s look closer at the one-two punch designed to break the bottleneck. 2. Intel + NVIDIANVIDIA put $5 billion into Intel (at $23.28/share), and the two agreed on a multi-year product collaboration. For Intel, that’s outside demand and credibility it badly needs. For NVIDIA, it’s a critical second source for advanced packaging and a new partner for custom silicon, reducing its dependency on a single supplier Three product updates at Intel
Subscribe to How They Make Money to unlock the rest.Become a paying subscriber of How They Make Money to get access to this post and other subscriber-only content. A subscription gets you:
|
Tuesday, September 23, 2025
🤝 Intel × NVIDIA Pact Explained
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment